| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | Dec 17, 2025 | Rezolute, Inc. | Chief Medical Officer | Buy | 86.3 | +28,000 | 9.46% | ✗ | $47.6K |
| Jun 25, 2025 | Jun 26, 2025 | Rezolute, Inc. | Chief Medical Officer | Buy | 91.3 | +2,500 | 17.39% | ✗ | $10.9K |
| Jun 14, 2024 | Jun 14, 2024 | Rezolute, Inc. | Chief Medical Officer | Buy | 91.3 | +7,600 | 12.43% | ✗ | $29.7K |
| May 23, 2024 | May 28, 2024 | Rezolute, Inc. | Chief Medical Officer | Buy | 91.3 | +7,500 | 13.99% | ✗ | $20.1K |
| Mar 28, 2024 | Mar 29, 2024 | Rezolute, Inc. | Chief Medical Officer | Buy | 67.5 | +500 | 0.94% | ✗ | $1.3K |
| Mar 14, 2024 | Mar 18, 2024 | Rezolute, Inc. | Chief Medical Officer | Buy | 91.3 | +10,000 | 23.19% | ✗ | $18.8K |
| Mar 7, 2024 | Mar 18, 2024 | Rezolute, Inc. | Chief Medical Officer | Buy | 77.5 | +500 | 1.17% | ✗ | $925 |
| Mar 7, 2024 | Mar 11, 2024 | Rezolute, Inc. | Chief Medical Officer | Buy | 77.5 | +500 | 1.18% | ✗ | $925 |
| Feb 23, 2024 | Feb 27, 2024 | Rezolute, Inc. | Chief Medical Officer | Buy | 91.3 | +8,000 | 23.15% | ✗ | $13.5K |
| Feb 16, 2024 | Feb 21, 2024 | Rezolute, Inc. | Chief Medical Officer | Buy | 90.0 | +7,000 | 25.41% | ✗ | $9.1K |
| Jul 3, 2023 | Jul 6, 2023 | Rezolute, Inc. | Chief Medical Officer | Buy | 90.0 | +5,000 | 22.17% | ✗ | $9.5K |
| May 17, 2022 | May 19, 2022 | Rezolute, Inc. | Sr VP, Clinic Development | Buy | 85.0 | +1,500 | 7.13% | ✗ | $4.9K |
| May 4, 2022 | May 6, 2022 | Rezolute, Inc. | Sr VP, Clinic Development | Buy | 95.0 | +21,052 | 100.00% | ✗ | $80K |